Vortioxetine Hydrobromide

CAS 960203-27-4 23 current recordsSmall Molecule

Who holds supplier records for Vortioxetine Hydrobromide? 23 organisations hold a current record for Vortioxetine Hydrobromide: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (15), China (3), Italy (1), Slovenia (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Vortioxetine Hydrobromide: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/vortioxetine-hydrobromide

Reading the evidence

  • 23 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    15 of the 21 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 13 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (23)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Vortioxetine Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

India15China3Italy1Slovenia1United States1Country not recorded for 2
Need Vortioxetine Hydrobromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Vortioxetine is an atypical antidepressant used in the treatment of major depressive disorder. It functions by modulating neurotransmitter activity in the brain through serotonin receptor antagonism and inhibition of serotonin reuptake.

Chemical identity

IUPAC name
1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine;hydrobromide
Canonical SMILES
CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br
InChIKey
VNGRUFUIHGGOOM-UHFFFAOYSA-N
Synonyms
Trintellix API, brintellix, lu aa 21004 hydrobromide, lu aa21004 hbr, lu-aa21004 hbr, lu-aa21004 hydrobromide, trintellix

Therapeutic areas

DepressionAnxietyMajor Depressive Disorder

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Vortioxetine Hydrobromide?

23 organisations hold an active US FDA Type II Drug Master File or a CEP for Vortioxetine Hydrobromide: BEIJING HOPE PHARMACEUTICAL CO LTD, MOREPEN LABORATORIES LTD (India), MSN PHARMACHEM PRIVATE LTD (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Zydus Lifesciences Limited (India), AARTI PHARMALABS LIMITED (India), Alembic Pharmaceuticals Limited (India) and ALP PHARM BEIJING CO LTD, and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Vortioxetine Hydrobromide Drug Master Files are active?

BEIJING HOPE PHARMACEUTICAL CO LTD (DMF 34873, 38974), MOREPEN LABORATORIES LTD (DMF 36753, 42252), MSN PHARMACHEM PRIVATE LTD (DMF 30309, 31411), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 40535, 31492), Zydus Lifesciences Limited (DMF 31726, 40772), AARTI PHARMALABS LIMITED (DMF 43908), Alembic Pharmaceuticals Limited (DMF 31281) and ALP PHARM BEIJING CO LTD (DMF 29849) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Vortioxetine Hydrobromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Vortioxetine Hydrobromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.